Progression free survival with endocrine therapy, before or after chemotherapy, in patients with hormone receptor-positive/HER2-negative metastatic breast cancer in a large multicenter national observational study

Affiliation auteurs!!!! Error affiliation !!!!
TitreProgression free survival with endocrine therapy, before or after chemotherapy, in patients with hormone receptor-positive/HER2-negative metastatic breast cancer in a large multicenter national observational study
Type de publicationJournal Article
Year of Publication2020
AuteursCorbaux P., Lardy-Cleaud A., Alexandre M., Fontanilles M., Levy C., Viansone A.A, Mailliez A., Debled M., Goncalves A., Le Du F., Lerebours F., Ferrero J-M., Eymard J-C., Mouret-Reynier M-A., Petit T., Frenel J-S., Pons-Tostivint E., Courtinard C., Chaix M., Bachelot T.
JournalANNALS OF ONCOLOGY
Volume31
PaginationS353
Date PublishedSEP
Type of ArticleMeeting Abstract
ISSN0923-7534
DOI10.1016/j.annonc.2020.08.382